期刊文献+

Solitaire AB支架取栓术治疗急性基底动脉闭塞8例报告 被引量:4

Mechanical Thrombectomy with the Solitaire AB device in Acute Basilar Artery Occlusion:a report of 8 cases
下载PDF
导出
摘要 目的探讨Solitaire AB型支架用于急性基底动脉闭塞动脉内取栓的疗效及安全性。方法回顾性分析我院2014年12月~2015年3月8例采用Solitaire AB型支架行急性基底动脉闭塞取栓术患者的临床资料。比较患者治疗前后美国国立卫生研究院卒中量表(NIHSS)评分及术后90 d mRs评分,评估患者预后状况。结果患者入院时NIHSS评分平均(20±3.3)分;6例患者成功再通,术后NIHSS评分改善≥14分,90 d随访临床结局优良;2例部分再通,术后发生出血转化且死亡。结论对急性基底动脉栓塞的患者,使用Solitaire AB型支架取栓术是相对安全、有效的。 Objective To explore and evaluate the efficacy and safety of mechanical thrombectomy with the Solitaire AB Revascularization Device in patients with acute basilar artery occlusion.Methods Eight patients with acute basilar artery occlusion were treated with using Solitaire AB stent retrievers between December 2014 and March 2015.Neurologic status was evaluated before and after treatment according to the National Institutes of Health Stroke Scale(NIHSS),and mRs90 days after stent placement.Results Median NIHSS score on admission was(20 ± 3.3) 。Successful recanalization was achieved in six patients,NIHSS improvement ≥14 points was reached in six patients.six patients had a favorable clinical outcome(mRS≤2).Hemorrhagic transformation occurred in two patients,and the two patients died.Conclusions Mechanical thrombectomy with the Solitaire AB stent in acute basilar artecr occlusion is relatively safe and effective
出处 《中风与神经疾病杂志》 CAS 北大核心 2016年第7期636-638,共3页 Journal of Apoplexy and Nervous Diseases
关键词 基底动脉闭塞 机械取栓 卒中 Basilar Artery Occlusion Mechanical Thrombectomy Stroke
  • 相关文献

参考文献1

二级参考文献99

  • 1Wahlgren N, Ahrced N, Davalos A, et al; SITS-MOST Investigators. Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITSMOST): an observational study. Lancet, 2007, 369: 275-282.
  • 2Lyden PD, ed. Thrombolytic Therapy for Acute Stroke. 2nd ed. Totowa, NJ: Hmreana Press, 2005.
  • 3Wardlaw JM, Smdercock PA, Berg: E. Throrrbolytic therapy with recoinbinant tissue plasminogen activator for acute ischemic stroke: where do we go from here? A cunaflative meta-analysis. Stroke, 2003, 34: 1437-1442.
  • 4Wardlaw JM, Zoppo G, Yamaguchi T, et al. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev, 2003, (4): CD000213.
  • 5Shanna M, Clark H, Armour T, et al. Acute stroke: evaluation and treatment. Evid Rep Technol Assess (Sunmm), 2005, (127): 1-7.
  • 6Hill MD, Buchan AM; Canadian Alteplase for Stroke Effectiveness Study (CASES) Investigators. Throrrbolysis for acute ischemic stroke: results of the Canadian Altephse for Stroke Effectiveness Study. CMAJ, 20(0, 172: 1307-1312.
  • 7Chung H, Refoios Canto R, Canto RR, et al. Alteplase for the treatment of acute ischaemic stroke: NICE technology appraisal guidance. Heart, 2007, 93: 1616-1617.
  • 8Saver JL, Smith EE, Fonarow GC, et al; GWTG-stroke Steering Committee and Investigators. The "golden hour" and acute brain ischemia: presenting features and lytic therapy in > 30,000 patients ariving within 60 minutes of stroke onset. Stroke, 2010, 41: 1431-1439.
  • 9Scott PA, Xu Z, Meurer WJ, et al. Attitudes and beliefs of Michigan emergmcy physicians toward tissue plasminogen activator use in stroke: baseline survey results from the INcreasing Stroke Treatment through INteractive behavioral Change Tactic (INSTINCT) trial hospitals. Stroke, 2010, 41: 2026-2032.
  • 10Kwiatkowski TG, Libman RB, Fmnkel M, et al. Effects of tissue plasrrfinogen activator for acute ischemic stroke at one year. National Institute of Neurological Disordeis and Stroke Recombinxaat Tissue Plasmiogen Activator Stroke Study Group. N Engl J Med, 1999, 340: 1781-1787.

共引文献987

同被引文献21

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部